Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2013
08/15/2013US20130209379 Lip cosmetic formulations
08/15/2013US20130209366 Glutathione-Lanthionine Compounds and Methods Related Thereto
08/15/2013US20130209364 Anti-Viral Azide Containing Compounds
08/15/2013CA2856403A1 Pharmaceutical compositions comprising deuterium-enriched perillyl alcohol, iso-perillyl alcohol and derivatives thereof
08/14/2013EP2626418A1 Method for activating helper t cell
08/14/2013EP2626357A1 Pyrrolic derivatives, processes for preparing the same and their uses as antibiotics
08/14/2013EP2626356A1 Thiamine analogues and their use as antibiotics
08/14/2013EP2626355A1 Process for the preparation of nilotinib hydrochloride
08/14/2013EP2626354A1 Viral polymerase inhibitors
08/14/2013EP2626353A1 Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
08/14/2013EP2626352A1 Heterocyclic low-molecular sapp mimetics, a pharmaceutical composition and methods for producing and using same
08/14/2013EP2626351A1 Agent for inhibiting expression of lipid metabolism related mrna
08/14/2013EP2626350A1 Cyclopropane compound
08/14/2013EP2626349A1 Amine compound and use for same
08/14/2013EP2626348A1 Heterocyclic amides as rock inhibitors
08/14/2013EP2626347A1 Dalfampridine polymorph, preparation therefor, and application thereof
08/14/2013EP2626083A1 Multi-arm polymer prodrugs
08/14/2013EP2626074A1 Methods and compositions for administration of iron
08/14/2013EP2626073A1 Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (PDE4)
08/14/2013EP2626072A1 Piperidine and piperazine derivatives as autotaxin inhibitors
08/14/2013EP2626071A1 Applications of arctigenin in formulating medicines for preventing or treating diseases related to red blood cell reduction
08/14/2013EP2626069A1 Prophylactic and/or therapeutic agent against lymphedema
08/14/2013EP2626068A1 Paracetamol for parenteral administration
08/14/2013EP2626067A1 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
08/14/2013EP2626066A1 Combination therapy comprising selective VEGFR-2 inhibitors and MEK inhibitors
08/14/2013EP2626065A1 Compound composition for inhalation used for treating asthma
08/14/2013EP2626063A1 Diclofenac gel
08/14/2013EP2625274A2 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
08/14/2013EP2625190A2 Derivatives of steroid benzylamines, having an antiparasitic, antibacterial, antimycotic and/or antiviral action
08/14/2013EP2625187A1 Phosphoramidite derivatives of gemcitabine for use in the treatment cancer
08/14/2013EP2625185A2 Anti-inflammatory macrolides
08/14/2013EP2625184A1 Antidiabetic enolic glucoside of phenylpyruvic acid
08/14/2013EP2625181A2 Method of preparation of antiviral compounds and useful intermediates thereof
08/14/2013EP2625180A2 Porphyrin treatment of neurodegenerative diseases
08/14/2013EP2625178A1 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls
08/14/2013EP2625177A1 Novel gpr 119 agonists
08/14/2013EP2625176A2 Substituted pyridazine carboxamide compounds
08/14/2013EP2625175A1 Crystalline (r) - (e) -2- (4- (2- (5- (1- (3, 5 -dichloropyridin-4 -yl) ethoxy) - 1h - indazol - 3 - yl) vinyl) -1 h- pyrazol- 1 -yl) ethanol and its use as fgfr inhibitor
08/14/2013EP2625174A1 Co-crystals and salts of ccr3-inhibitors
08/14/2013EP2625173A2 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
08/14/2013EP2625172A1 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid
08/14/2013EP2625169A1 Quinazoline compounds as sodium channel blockers
08/14/2013EP2625168A1 Phenyl diamides and a pharmaceutical preparation comprising phenyl diamides
08/14/2013EP2625167A1 Salts and polymorphs of sulfamide ns3 inhibitors
08/14/2013EP2625162A1 Methods of making l-ornithine phenyl acetate
08/14/2013EP2624916A2 Compositions and methods for treating ocular edema, neovascularization and related diseases
08/14/2013EP2624874A1 Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
08/14/2013EP2624869A2 Prodrugs utilizing a transporter directed uptake mechanism
08/14/2013EP2624866A2 Tumor specific antibodies and uses therefor
08/14/2013EP2624858A1 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
08/14/2013EP2624848A2 Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
08/14/2013EP2624842A2 Use of hyaluronan for promoting angiogenesis
08/14/2013EP2624841A1 Compositions for treating chronic viral infections
08/14/2013EP2624840A1 New treatments of hepatitis c virus infection
08/14/2013EP2624839A1 Composition for use in the treatment of acne
08/14/2013EP2624838A1 Novel combinations
08/14/2013EP2624837A2 Novel inhibitors of secretion of hepatitis b virus antigens
08/14/2013EP2624836A2 Bepotastine compositions
08/14/2013EP2624835A2 Compositions for treating psoriasis of the scalp
08/14/2013EP2624834A1 Macrocyclic lactone compounds and methods for their use
08/14/2013EP2624833A1 4- (methylaminophenoxy) pyrdin- 3 - yl - benzamide derivatives for treating cancer
08/14/2013EP2624832A1 Hdac inhibitors to treat charcot-marie-tooth disease
08/14/2013EP2624831A1 Pharmaceutical combinations
08/14/2013EP2624830A2 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity
08/14/2013EP2624829A1 Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria
08/14/2013EP2624828A1 Picropodophyllin monohydrate or polymorph a in cancer therapy
08/14/2013EP2624827A1 Picropodophyllin polymorphs b or c for use in cancer therapy
08/14/2013EP2624826A1 Vitamin e formulations of sulfamide ns3 inhibitors
08/14/2013EP2624825A2 Materials and methods for improving gastrointestinal function
08/14/2013EP2624823A2 Administration of serine protease inhibitors to the stomach
08/14/2013EP2624822A2 Allergen deactivator composition, articles and methods
08/14/2013EP2624821A1 Combination therapy for the treatment of depression and other non-infectious diseases
08/14/2013EP2624820A2 Antimicrobial preservation of propofol emulsions
08/14/2013EP2624818A1 Bortezomib formulations stabilised with boric
08/14/2013EP2624817A1 Novel composition
08/14/2013EP2624816A2 Stimulation of neuroregeneration by flavonoid glycosides
08/14/2013EP2624698A1 FURO[3,2-d]PYRIMIDINE COMPOUNDS
08/14/2013EP2624697A1 Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators
08/14/2013EP2624696A1 Benzimidazole derivatives as pi3 kinase inhibitors
08/14/2013EP2624695A1 Novel substituted quinoline compounds as s-nitrosoglutathione reductase inhibitors
08/14/2013DE102012003065A1 New bivalent gamma-carboline derivatives, useful as anti-dementia drugs, cognition enhancers and/or substance for increasing memory capacity
08/14/2013DE102012002592A1 Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP) Use of an agent for the stimulation of gene expression of antimicrobial peptides (AMP)
08/14/2013DE102006008074B4 Behandlung von Krebs mit Geruchsrezeptor-Liganden Treatment of cancer with olfactory receptor ligands
08/14/2013CN203123076U Telmisartan/amlodipine tablet
08/14/2013CN203123075U Photochromic anti-acne repair membrane sheet
08/14/2013CN1869080B Inverse latices of copolymers of amps and of N,N-dimethylacrylamide, cosmetic use
08/14/2013CN1615141B Use of polysaccharide derivatives as anti-infective substances
08/14/2013CN103249741A Peptide
08/14/2013CN103249737A Boronates as arginase inhibitors
08/14/2013CN103249735A Tricyclic compounds and methds of making and using same
08/14/2013CN103249733A Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
08/14/2013CN103249732A Bacteria topoisomerase II inhibiting 2-thylcarbamoylamino-1, 3-benzothiazol-5-yls
08/14/2013CN103249731A Hepatitis c virus inhibitors
08/14/2013CN103249730A Hepatitis c virus inhibitors
08/14/2013CN103249728A Novel triazole compounds III
08/14/2013CN103249727A New biaryl amide derivatives
08/14/2013CN103249726A Acylbenzene derivative
08/14/2013CN103249723A Pyrazine derivatives as enac blockers
08/14/2013CN103249721A Arylamide derivatives as TTX-S blockers
08/14/2013CN103249720A Oxime compounds as HDL-holesterol raising agents
1 ... 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 ... 7860